Robert Levy - Publications

Affiliations: 
University of Miami, Coral Gables, FL 

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Müller AM, Min D, Wernig G, Levy RB, Perez VL, Herretes S, Florek M, Burnett C, Weinberg K, Shizuru JA. Modeling chronic Graft-vs-Host disease in MHC-matched mouse strains: genetics, graft composition and tissue targets. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31415899 DOI: 10.1016/j.bbmt.2019.08.001  0.48
2019 Copsel S, Wolf D, Komanduri KV, Levy RB. The promise of CD4+FoxP3+ regulatory T cell manipulation in vivo: applications for allogeneic hematopoietic stem cell transplantation. Haematologica. PMID 31221786 DOI: 10.3324/haematol.2018.198838  0.48
2018 Copsel SN, Lightbourn CO, Barreras H, Lohse I, Wolf D, Bader CS, Manov J, Kale BJ, Shah D, Brothers SP, Perez VL, Komanduri KV, Wahlestedt C, Levy RB. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT. Frontiers in Immunology. 9: 3104. PMID 30733722 DOI: 10.3389/fimmu.2018.03104  0.48
2018 Wolf D, Bader CS, Barreras H, Copsel S, Pfeiffer BJ, Lightbourn CO, Altman NH, Komanduri KV, Levy RB. Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models. Jci Insight. 3. PMID 30333311 DOI: 10.1172/jci.insight.121717  0.48
2018 Copsel S, Wolf D, Kale B, Barreras H, Lightbourn CO, Bader CS, Alperstein W, Altman NH, Komanduri KV, Levy RB. Very Low Numbers of CD4FoxP3 Tregs Expanded in Donors via TL1A-Ig and Low Dose IL-2 Exhibit a Distinct Activation / Functional Profile and Suppress GVHD in a Pre-Clinical Model. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29751114 DOI: 10.1016/j.bbmt.2018.04.026  0.48
2017 Wolf D, Barreras H, Bader CS, Copsel S, Lightbourn CO, Pfeiffer BJ, Altman NH, Podack ER, Komanduri KV, Levy RB. Marked in vivo Donor Treg Expansion via IL-2 and TL1A-Ig Stimulation Ameliorates GVHD but Preserves GVL in Recipients Post-HSCT. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28219835 DOI: 10.1016/j.bbmt.2017.02.013  0.48
2016 Perez VL, Barsam A, Duffort S, Urbieta M, Barreras H, Lightbourn C, Levy RB. Novel Scoring Criteria for the Evaluation of Ocular Graft Versus Host Disease in a Pre-Clinical Allo-HSCT Animal Model. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27492793 DOI: 10.1016/j.bbmt.2016.07.012  0.48
2015 Herretes S, Ross DB, Duffort S, Barreras H, Yaohong T, Saeed AM, Murillo JC, Komanduri KV, Levy RB, Perez VL. Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants. Investigative Ophthalmology & Visual Science. 56: 2348-57. PMID 25655798 DOI: 10.1167/iovs.14-15630  1
2014 Ganguly S, Ross DB, Panoskaltsis-Mortari A, Kanakry CG, Blazar BR, Levy RB, Luznik L. Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice. Blood. 124: 2131-41. PMID 25139358 DOI: 10.1182/blood-2013-10-525873  1
2014 Newman RG, Dee MJ, Malek TR, Podack ER, Levy RB. Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice. Blood. 123: 3045-55. PMID 24687086 DOI: 10.1182/blood-2013-08-520775  1
2013 Newman RG, Ross DB, Barreras H, Herretes S, Podack ER, Komanduri KV, Perez VL, Levy RB. The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success. Immunologic Research. 57: 125-39. PMID 24272856 DOI: 10.1007/s12026-013-8450-7  1
2013 Komanduri KV, Wieder ED, Benjamin CL, Levy RB. The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression. Immunologic Research. 57: 140-50. PMID 24242818 DOI: 10.1007/s12026-013-8461-4  1
2013 Ross D, Jones M, Komanduri K, Levy RB. Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1430-8. PMID 23819914 DOI: 10.1016/j.bbmt.2013.06.019  1
2013 Shindo T, Kim TK, Benjamin CL, Wieder ED, Levy RB, Komanduri KV. MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner. Blood. 121: 4617-26. PMID 23575444 DOI: 10.1182/blood-2012-12-476218  1
2007 Keith MR, Levy RB. Transplant conditions determine the contribution of homeostatically expanded donor CD8 memory cells to host lymphoid reconstitution following syngeneic HCT. Experimental Hematology. 35: 1303-15. PMID 17553613 DOI: 10.1016/j.exphem.2007.04.008  1
2006 Barao I, Hanash AM, Hallett W, Welniak LA, Sun K, Redelman D, Blazar BR, Levy RB, Murphy WJ. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 5460-5. PMID 16567639 DOI: 10.1073/pnas.0509249103  1
2005 Hanash AM, Levy RB. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood. 105: 1828-36. PMID 15494429 DOI: 10.1182/blood-2004-08-3213  1
2004 Marks L, Altman NH, Podack ER, Levy RB. Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients. Transplantation. 77: 804-12. PMID 15077018 DOI: 10.1097/01.TP.0000110416.96307.D5  1
2004 Marks L, Levy RB. The cytotoxic potential of regulatory T cells: what has been learned from gene knockout model systems? Transplantation. 77: S19-22. PMID 14726764 DOI: 10.1097/01.TP.0000106473.46037.83  1
2002 Jiang Z, Adams GB, Hanash AM, Scadden DT, Levy RB. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 8: 588-96. PMID 12463477  1
Show low-probability matches.